Portrait of Park Soon-jae

Rank #1762

Park Soon-jae

Net worth $2.4B

Biopharmaceuticals · South Korea

Born
Dec 22, 1954
Age
71
Source
Biopharmaceuticals
Residence
Daejeon
Citizenship
South Korea
Marital status
Married
Children
0
Education
Ph.D, Purdue University

Net worth over time

Biography

  • Park Soon-jae is cofounder and CEO of South Korean biotechnology company Alteogen, which focuses on biosimilars and bio-betters.
  • Alteogen is known for its ALT-B4, an enzyme with technology that allows drugs to be administered subcutaneously instead of intravenously.
  • In 2024, Alteogen revealed Merck had agreed to a licensing deal to use ALT-B4 for the drug giant's cancer drug pembrolizumab. Alteogen shares soared 25% in a day following the announcement.
  • Park's wife, Chung Hye-shin, served as the company's chief strategy officer until 2023.
  • Prior to cofounding Alteogen in 2008, Park worked at LG Life Sciences and Hanwha Petrochemical, and was a postdoctoral researcher at MIT.

Financial assets

Exchange Ticker Company Shares Price Currency